The combined effect of serum cystatin C and dyslipidemia on hypertension in a large health check-up population in China
OBJECTIVE: Some studies have reported that both serum cystatin C (Cys C) and dyslipidemia are independently associated with hypertension. However, the combined effect of the two factors is still unknown. The present study was aimed at investigating the effect of Cys C combined with dyslipidemia on h...
Main Authors: | Jun Ma, Zewei Wu, Xiaojuan Zha, Xinying Zhu, Wenbo Li, Mingfei Jiang, Shuyi Wang, Shouzhi Wu, Yufeng Wen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-11-01
|
Series: | Clinical and Experimental Hypertension |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10641963.2018.1545845 |
Similar Items
-
Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
by: Tadesse Asmamaw Dejenie, et al.
Published: (2023-04-01) -
Serum Cystatin C as a Biomarker for Early Diabetic Kidney Disease and Dyslipidemia in Young Type 1 Diabetes Patients
by: Ingrida Stankute, et al.
Published: (2022-02-01) -
Clinical Usefulness of Serum Cystatin C as a Marker of Renal Function
by: Kwang-Sook Woo, et al.
Published: (2014-08-01) -
Cystatin C as an indicator of renal damage in pre-eclampsia
by: Hellen Cássia Dos Santos Gomes, et al.
Published: (2020-07-01) -
Cystatin C versus Creatinine as Early Stage Diabetic Nephropathy Marker
by: Atteaya Zaman , Amena Rahim , Muhammad Afzal , Abdul Khaliq Naveed
Published: (2018-06-01)